New drugs and dosage forms

December 2009
American Journal of Health-System Pharmacy;12/1/2009, Vol. 66 Issue 23, p2070
Academic Journal
Product Review
The article evaluates several drugs which includes Berinert, a C1-esterase inhibitor of CSL Behring LLC, Cervarix, a Human papillomavirus bivalent vaccine suspension of GlasoSmithKline and Votrient, a Pazopanib tablets of Votrient, GlaxoSmithKline.


Related Articles

  • product showcase.  // Pharmacy Today;Mar2009, Vol. 15 Issue 3, p16 

    The article evaluates several drugs including Ria-STAP human fibrinogen concentrate from CSL Behring, Kapidex dexlansoprazole delayed release capsules from Takeda and Vertical Calcitriol ointment 3mcg/g from Galderma Laboratories LP.

  • NEW INDICATIONS.  // Drug Topics;6/4/2007, Vol. 151 Issue 11, p67 

    The article evaluates several drugs including CSL Behring's Humate-P for the treatment and prevention of bleeding in hemophilia A patients, Oscient Pharmaceuticals Corp.'s Factive Tablets for the treatment of mild to moderate community-acquired pneumonia and Duramed Pharmaceuticals Inc.'s...

  • New class of drugs targeting Type 2 diabetes. Fernandez, Julio // Drug Topics;10/13/2008, Vol. 152 Issue 11, p6s 

    The article evaluates two drugs for the type 2 diabetes treatment which includes the Januvia (sitagliptin) from Merck & Co. Inc. and Exenatide (Byetta) from Eli Lilly & Co.

  • Benlysta Gets Priority Review.  // Contract Pharma;Sep2010, Vol. 12 Issue 7, p130 

    The article offers updates on several drug developments in the U.S. Phase one study of BioMarin Pharmaceutical Inc. development of the BMN 195 drug has been completed. Clinuvel Pharmaceuticals Ltd. has successfully achieved a positive result on its Phase III trial of the drug Scenesse. The U.S....

  • DULOXETINE APPROVED FOR FIBROMYALGIA.  // RN;Jul2008, Vol. 71 Issue 7, p24 

    The article reports on the approval granted by the U.S. Food and Drug Administration (FDA) to duloxetine HCl (Cymbalta), a serotonin-norepinephrine reuptake inhibitor, for fibromyalgia patients.

  • Kids get new upset-stomach remedy.  // Drug Store News;12/10/2007, Vol. 29 Issue 15, p37 

    The article evaluates the Tums Kids' stomach relief product from the GlaxoSmithKline company.

  • POTIGA.  // Monthly Prescribing Reference;Jul2012, Vol. 28 Issue 7, pA5 

    The article offers brief information on Potiga drug from GlaxoSmithKline.

  • GSK ends Serevent study after FDA analysis. Dickinson, James D. // Medical Marketing & Media;Mar2003, Vol. 38 Issue 3, p28 

    Reports on the conclusion of an interim analysis of the asthma drug Serevent from GlaxoSmithKline Inc. in the U.S. Difficulties in enrollment; Absence of significant result on the primary endpoint; Need for doctor's consultation in taking Serevent.

  • Anoro Ellipta.  // MPR - Pharmacist's Edition;Summer2014, Vol. 8 Issue 2, pA8 

    The article offers brief information on the drug Anoro Ellipta from GlaxoSmithKline.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics